Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 4/20 | 0.57 |
| ▸ | FGF1 | P05230 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | G6PD | P11413 | 3/20 | 0.36 |
| ▸ | SERPINC1 | P01008 | 1/20 | 0.34 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18346803 | 1.00 | F10 (0.57) | F10FGF1CA2CA9CA1 | |
| SCHEMBL11921954 | 0.85 | F10 (0.46) | F10FGF1CA2CA9CA1 | |
| SCHEMBL17002053 | 0.84 | CA2 (0.47) | F10FGF1CA2CA9CA1 | |
| SCHEMBL13286928 | 0.82 | F10 (0.42) | F10FGF1CA2CA9CA1 | |
| SCHEMBL1009127 | 0.82 | F10 (0.42) | F10FGF1CA2CA9CA1 | |
| SCHEMBL16728926 | 0.82 | F10 (0.42) | F10FGF1CA2CA9CA1 | |
| SCHEMBL7209918 | 0.82 | F10 (0.42) | F10FGF1CA2CA9CA1 | |
| SCHEMBL21067663 | 0.82 | F10 (0.42) | F10FGF1CA2CA9CA1 | |
| SCHEMBL20987120 | 0.82 | F10 (0.42) | F10FGF1CA2CA9CA1 | |
| SCHEMBL7209912 | 0.82 | F10 (0.42) | F10FGF1CA2CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9211305-B2 | Pharmaceutical compositions with glycosaminoglycans and use thereof in the treatment of chronic ulcers | Laboratories Farmaceuticos Roui, S.A. (ES) | 2015-12-15 | — | — | US | disclosed |